This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Ruben Postel
CSO & Scientific Founder at Sapreme Technologies
Speaker

Profile

Ruben is the Chief Scientific Officer and Founder of Sapreme. At Sapreme, he steers the scientific developments and innovation of the company to enable the challenge of endosomal entrapment of payloads, paving the way for next-generation therapeutic development. Ruben earned his Ph.D. in Developmental Biology and Genetics from the Hubrecht Institute and worked as a postdoctoral fellow at The Netherlands Cancer Institute in the department of Cell Biology. Before founding Sapreme Technologies, he gained experience in the ecosystem of biotech startups working on the development of tumor angiogenesis inhibitors.

Agenda Sessions

  • AOSCs: Improved Antibody-oligonucleotide Conjugates with Integrated Endosomal Release

    11:15